Enlivex Therapeutics Ltd. (ENLV)
1.15
0.01 (0.88%)
At close: Jan 15, 2025, 1:26 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -29.07M | -31.06M | -14.47M | -11.82M | -9.38M | -4.24M | -5.95M | -16.02M | -15.37M | -7.02M | -1.15M | -229.00K |
| Depreciation & Amortization | 835.00K | 777.00K | 546.00K | 286.00K | 206.00K | 121.00K | 64.00K | 38.00K | 17.00K | 5.00K | n/a | n/a |
| Stock-Based Compensation | 1.95M | 2.71M | 2.91M | 670.00K | 810.00K | 1.01M | 408.00K | 700.00K | 2.62M | 736.00K | 254.00K | 9.00K |
| Other Working Capital | -1.30M | -364.00K | -1.80M | -342.00K | 926.00K | -62.00K | 18.00K | 471.00K | -740.00K | -249.00K | 54.00K | -3.00K |
| Other Non-Cash Items | 4.58M | 2.81M | 413.00K | 167.00K | 168.00K | -132.00K | 7.00K | 39.00K | -18.00K | -28.00K | 254.00K | n/a |
| Deferred Income Tax | n/a | n/a | -5.59M | n/a | 119.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -1.82M | 804.00K | -1.36M | -306.00K | 1.04M | 83.00K | -886.00K | -241.00K | -506.00K | 1.90M | 26.00K | 71.00K |
| Operating Cash Flow | -23.52M | -23.95M | -17.54M | -11.01M | -7.04M | -3.16M | -6.35M | -15.49M | -13.25M | -4.41M | -865.00K | -149.00K |
| Capital Expenditures | -236.00K | -8.12M | -1.63M | -1.02M | -193.00K | -461.00K | -2.00K | -18.00K | -48.00K | -63.00K | -2.00K | n/a |
| Acquisitions | n/a | -9.71M | -20.03M | n/a | 1.55M | n/a | 9.00K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -26.17M | -1.61M | -104.42M | -19.96M | -7.71M | -40.00K | n/a | n/a | n/a | -22.00M | n/a | n/a |
| Sales Maturities Of Investments | 301.00K | 72.25M | 67.63M | n/a | -1.55M | n/a | 3.00M | 9.00M | 10.00M | n/a | n/a | n/a |
| Other Investing Acitivies | 133.00K | 9.71M | 20.03M | -19.96K | 1.55M | -32.00K | 3.01M | 9.00M | 10.00M | -22.00M | n/a | n/a |
| Investing Cash Flow | -25.97M | 62.52M | -38.41M | -20.98M | -6.36M | -533.00K | 3.01M | 8.98M | 9.95M | -22.06M | -2.00K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 150.00K | 7.81M | 8.62M | 599.00K | 5.19M | n/a | n/a | 36.78M | n/a | n/a | n/a |
| Financial Cash Flow | 360.00K | 150.00K | 60.98M | 33.08M | 8.31M | 5.19M | 8.05K | 6.09M | 36.78M | 36.78M | 991.00K | 295.00K |
| Net Cash Flow | -49.13M | 38.72M | 4.62M | 1.49M | -4.27M | 731.00K | -3.35M | -415.00K | -3.30M | 10.31M | 124.00K | 146.00K |
| Free Cash Flow | -23.76M | -32.08M | -19.17M | -12.03M | -7.23M | -3.62M | -6.35M | -15.50M | -13.30M | -4.47M | -867.00K | -149.00K |